Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
BeiGene (OTCMKTS: BEIGF)
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
BeiGene Ltd is a commercial-stage biotechnology company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1. Its geographical segments are China, the United States, and the Rest of the world.
| Last: | $23.75 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $23.75 |
| Close: | $23.75 |
| High: | $23.75 |
| Low: | $23.75 |
| Volume: | 500 |
| Last Trade Date Time: | 03/16/2026 09:30:02 am |
| Market Cap: | $38,603,023,416 |
|---|---|
| Float: | 747,457,849 |
| Insiders Ownership: | N/A |
| Institutions: | 299 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.beonemedicines.com |
| Country: | CH |
| City: | Basel |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about BeiGene (OTCMKTS: BEIGF).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
